| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.03B | 2.19B | 2.39B | 2.95B | 3.53B |
| Gross Profit | 257.51M | 306.51M | 388.91M | 419.85M | 478.19M |
| EBITDA | -13.63M | 96.96M | 301.63M | 211.54M | 200.89M |
| Net Income | -78.94M | -43.36M | 135.16M | 66.04M | 51.95M |
Balance Sheet | |||||
| Total Assets | 3.21B | 3.44B | 3.81B | 3.99B | 4.30B |
| Cash, Cash Equivalents and Short-Term Investments | 658.29M | 975.48M | 1.12B | 1.25B | 1.07B |
| Total Debt | 53.34M | 101.61M | 165.06M | 229.60M | 200.60M |
| Total Liabilities | 421.56M | 476.96M | 636.06M | 795.10M | 957.81M |
| Stockholders Equity | 2.68B | 2.84B | 3.05B | 3.05B | 3.19B |
Cash Flow | |||||
| Free Cash Flow | -203.69M | 30.36M | 13.71M | 285.98M | -338.21M |
| Operating Cash Flow | -94.57M | 88.04M | 277.57M | 455.95M | -161.56M |
| Investing Cash Flow | -4.42M | 36.49M | -240.51M | -3.28M | 7.07M |
| Financing Cash Flow | -160.70M | -204.57M | -208.51M | -135.01M | -66.99M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$955.14M | 5.59 | 11.76% | 7.86% | -9.79% | -12.85% | |
68 Neutral | HK$201.96M | 7.60 | 8.42% | 18.18% | -3.56% | -16.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$211.20M | 7.19 | -23.30% | 8.60% | -3.83% | -698.65% | |
54 Neutral | HK$155.69M | 4.19 | 10.09% | ― | -6.56% | ― | |
48 Neutral | HK$729.70M | -10.57 | -2.27% | 13.04% | -7.73% | -82.01% | |
43 Neutral | HK$10.75M | -0.48 | ― | ― | -55.61% | 19.25% |